Navigation Links
China Pharma Holdings, Inc. Announces First Quarter 2008 Financial Results
Date:5/2/2008

ld decreased from 19.3% of total A/R at March 31, 2007, to 7.9% at March 31, 2008. Net cash flow from operating activities was $1.5 million in the three months ended March 31, 2008, compared to negative $2.2 million during the same time in the prior year. The improvement in operating cash flow was primarily due to the increase of net income and collection of older trade accounts receivables.

Ms. Li concluded, "In the first quarter of 2008, our acceleration in organic growth from our existing core products and new products launched after 2006 demonstrates the success of our dual growth strategy. China Pharma continues to focus on developing and marketing improved generic products for high incidence and high mortality diseases particular to the China market. With the rapidly growing economy and the Chinese Government's commitment to expand its rural cooperative medical system (CMS) by spending $1.3 billion to increase coverage from 51% to 100% in rural areas, we are well positioned in the Chinese pharmaceutical industry to continue to grow our revenue and net income throughout 2008 and beyond."

Conference Call

China Pharma will host a conference call on Tuesday, May 6 at 10:00 am EDT to discuss first quarter 2008 results. To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: (800) 591-6942 International callers should dial (617) 614-4909. The conference pass code is 32765641.

If you are unable to participate in the call at this time, a replay will be available on Tuesday, May 6, at 12:00 pm EDT, through Tuesday, May 13. To access the replay, dial (888) 286-8010. International callers should dial (617) 801-6888. The conference pass code is 89227480.

This conference call will be broadcast live over the Internet and can be accessed by copying and pasting this link into your web browser:

SOURCE China Pharma Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. DuPont Partnering with China to Increase Farm Productivity
3. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
4. China Sky One Medical, Inc. Acquires Heilongjiang Haina Pharmaceutical Inc.
5. Syngenta To Build Major Global Biotech Research Center in Beijing, China
6. American Oriental Bioengineering and China Aoxing Pharmaceutical Enter Into Strategic Alliance
7. China YCT International Group, Inc. Announces Entrusted Management Agreement With Its Primary Supplier
8. CTDC Attends the Inauguration Ceremony of Thin Film A-Si Manufacturing Line in Changzhou, China
9. China Bio Energy Reports Fiscal 2007 Financial Results
10. Transgenomic Opens Pharmacogenomics Laboratory in China
11. China Pharma Holdings, Inc. Announces Record 2007 Year End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014   SunTrust Robinson ... three industry veterans to its equity research team ... "Our ongoing expansion in equity research demonstrates our ... unique insights to enhance their investment decision making," ... at STRH.  "We continue to make significant investments ...
(Date:8/28/2014)... 2014 Scientists, researchers, and technologists will ... Laser Damage 2014 symposium. Marking its 46th year, ... will run 14-17 September. The event is sponsored by ... . , The premier conference for basic and applied ... optical materials will engage researchers and engineers from numerous ...
(Date:8/28/2014)... Supplementing their complete line of ... Eppendorf Safe Lock Centrifuge Tubes . This ... quality tubes at an affordable price. Eppendorf Safe ... chemical, medical, pharmaceutical, and life science research and ... able to afford Eppendorf products. , Eppendorf is ...
(Date:8/27/2014)... Aug. 27, 2014 Rhythm, a biopharmaceutical company ... deficiencies that result in metabolic disorders, announced today that ... with the U.S. Securities and Exchange Commission (SEC) relating ... its common stock. The number of shares to be ... not yet been determined. Citigroup and Cowen ...
Breaking Biology Technology:SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 2Laser Damage to Draw Researchers, Engineers, Scientists to 46th Annual Conference 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor Pipette.com 3Rhythm Files Registration Statement for Proposed Initial Public Offering 2
... striving to develop organic solar cells that can be produced ... used to generate electricity. But a major obstacle is ... at the nanoscale (tinier than 2-millionths of an inch) to ... is to develop cells made from low-cost plastics that will ...
... 4 Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ) will hold ... to discuss the second quarter 2009 financial results and business outlook for ... Company, will host the call. Keryx will announce its financial results ... the call. , , In order to participate in ...
... Nile Therapeutics, Inc. (Nasdaq: NLTX ), a company ... today announced dosing of its first patient in a Phase 2 ... acute heart failure. , , The single-blind, placebo-controlled ... safety and tolerability of CD-NP when infused for up to 72 ...
Cached Biology Technology:Plastics that convert light to electricity could have a big impact 2Plastics that convert light to electricity could have a big impact 3Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2009 Financial Results on Thursday, August 6, 2009 at 8:30am EDT 2Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure 2Nile Therapeutics, Inc. Announces Dosing of First Patient in Phase 2 Study of CD-NP for the Treatment of Acute Heart Failure 3
(Date:8/27/2014)... that a single fungal cell or bacterial colony exerts on ... a heavy role in setting up some of the most ... be too much of a stretch to say that plants ... respond to the touch of beneficial fungi, according to a ... at the University of Wisconsin-Madison. , "Many people have ...
(Date:8/27/2014)... mysteries of the human genome was unveiled today in ... detailed comparison yet of how the genomes of the ... research, appearing August 28 in in the journal ... three species, genomes is "read out," and how their ... results add billions of entries to a publicly available ...
(Date:8/27/2014)... a gene that could help scientists engineer drought-resistant crops. ... cell membrane of plants that senses changes in water ... , "It,s similar to a thermostat," said Zhen-Ming ... , The findings, which appear Aug. 28 in the ... feed the world,s growing population in the face of ...
Breaking Biology News(10 mins):A touching story: The ancient conversation between plants, fungi and bacteria 2A touching story: The ancient conversation between plants, fungi and bacteria 3Encyclopedia of how genomes function gets much bigger 2Encyclopedia of how genomes function gets much bigger 3Encyclopedia of how genomes function gets much bigger 4Water 'thermostat' could help engineer drought-resistant crops 2
... -- In the summer of 1968, a new strain of ... spread around the globe and eventually killed an estimated 1 ... there are many strains of H3N2 circulating in birds and ... have the potential to generate a pandemic if they leap ...
... from the David Geffen School of Medicine at UCLA have ... of Sciences in recognition of their distinguished and continuing achievements ... is considered one of the highest honors presented to scientists ... Thomas Edison, Orville Wright and Alexander Graham Bell. ...
... a new door to developing drugs to slow the ... Edward A. Fon at the Montreal Neurological Institute and ... in the Department of Biochemistry at the Faculty of ... Parkin. Mutations in Parkin cause a rare hereditary form ...
Cached Biology News:Potential flu pandemic lurks 2Potential flu pandemic lurks 32 UCLA faculty elected to National Academy of Sciences 2Unleashing the watchdog protein 2
... The Varian 500-MS LC Ion Trap ... high-throughput LC/MS analysis where sensitivity, reliability ... 500-MS provides a robust platform for ... mass resolution, and mass stability reflect ...
... General description: The Costar strip ejector ... easy removal of Costar strips from their ... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ...
Sigmas E-TOXATE (Limulus Amebocyte Lysate) test kits are intended for the detection and semiquantitation,of endotoxins for research purposes....
... These versatile enclosures ... with nitrogen or other ... a low-humidity environment. HEPA ... and ionization modules also ...
Biology Products: